Friday, 13 November 2026European Markets

TER BEKE, ORKLA, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Consumer Defensive Sector.

Loading stream...

(VIANEWS) - TER BEKE (TERB.BR) is among this list of stock assets with the highest dividend rate and return on equity on the Consumer Defensive sector.

Financial Asset Price Forward Dividend Yield Return on Equity
TER BEKE (TERB.BR) €87.80 4.94% 3.73%
ORKLA (ORK.OL) kr71.08 4.26% 12.77%
GLANBIA PLC (GL9.IR) €12.86 2.55% 11.06%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. TER BEKE (TERB.BR)

4.94% Forward Dividend Yield and 3.73% Return On Equity

Ter Beke NV, together with its subsidiaries, develops, produces, and sells a range of processed meat products and ready meals to discount and retail clients in Europe. It operates through two segments, Processed Meats and Ready Meals. The Processed Meats segment develops, produces, and sells a range of processed meats, including salami, cooked ham, poultry, other cooked meats, pâtés, preserved meats, tongue, and liver products under the Pluma, Daniël Coopman, Zonnenberg, Kraak-Vers, and FairBeleg brand names, as well as other private labels. The Ready Meals segment develops, produces, and sells freshly prepared ready meals including lasagne, pizza, pasta dishes, and sauces under the Come a casa, Vamos, and Stefano Toselli brand names, as well as private labels. Ter Beke NV was founded in 1948 and is based in Gent, Belgium. Ter Beke NV is a subsidiary of Stak Coovan.

Earnings Per Share

As for profitability, TER BEKE has a trailing twelve months EPS of €-1.36.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.73%.

Volume

Today's last reported volume for TER BEKE is 411 which is 25.94% below its average volume of 555.

More news about TER BEKE.

2. ORKLA (ORK.OL)

4.26% Forward Dividend Yield and 12.77% Return On Equity

Orkla ASA engages in branded consumer goods, and industrial and financial investment businesses. The company offers branded products, including frozen pizza, ketchup, soups, sauces, bread toppings, and ready-to-eat meals through grocery retail trade, as well as the out-of-home, convenience store, and petrol station sectors. It also provides confectionery, biscuit, and snack products; and develops crispbread products, as well as energy snack meals. In addition, the company offers personal care and cleaning products; dietary supplement, sport nutrition, and weight control products; wound care products and first aid equipment; painting tools; basic garments; and professional cleaning products. Further, it operates Gymgrossisten and Bodystore e-commerce portals for health and sports nutrition products; and restaurants. Additionally, the company supplies margarine and butter blends, bread and cake improvers and mixes, yeast, marzipan, and ice cream ingredients; produces and supplies hydro power to the Nordic power market; and develops and sells real estate properties. It offers its food products under the Grandiosa, TORO, Stabburet, Felix, Paulúns, Abba, Kalles, Beauvais, Den Gamle Fabrik, Spilva, Vitana, MTR, and Eastern brands; confectionery and snacks under the KiMs, Nidar, Stratos, Göteborgs Kex, Sætre, OLW, Panda, Laima, Selga, Taffel, Adazu, and Kalev brands; health and sports nutrition under Zalo, Jif, Bliw, Grumme, Blenda, Define, Möller's, Collett, Nutrilett, Maxim, Norgesplaster, and Salvequick brands; and food ingredients under Odense, Mors Hjemmebakte, KronJäst, Bakkedal and NATURLI' brands. It has operations in Norway, Sweden, Denmark, Finland, Iceland, the Baltics, rest of Europe, and internationally. The company is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, ORKLA has a trailing twelve months EPS of kr4.37.

PE Ratio

ORKLA has a trailing twelve months price to earnings ratio of 16.27. Meaning, the purchaser of the share is investing kr16.27 for every norwegian krone of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.77%.

Volatility

ORKLA's last week, last month's, and last quarter's current intraday variation average was 0.38%, 0.11%, and 0.59%.

ORKLA's highest amplitude of average volatility was 0.45% (last week), 0.54% (last month), and 0.59% (last quarter).

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter and the next is a negative 12.1% and a negative 14.3%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ORKLA's EBITDA is 33.43.

Moving Average

ORKLA's value is below its 50-day moving average of kr72.18 and below its 200-day moving average of kr75.57.

More news about ORKLA.

3. GLANBIA PLC (GL9.IR)

2.55% Forward Dividend Yield and 11.06% Return On Equity

Glanbia plc operates as a nutrition company worldwide. The company manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, online, and gyms, as well the food, drug, mass, and club channels. It engages in the manufacture and sale of cheese, dairy, and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes. In addition, the company engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It operates a portfolio of brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT brands. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

Earnings Per Share

As for profitability, GLANBIA PLC has a trailing twelve months EPS of €0.49.

PE Ratio

GLANBIA PLC has a trailing twelve months price to earnings ratio of 26.46. Meaning, the purchaser of the share is investing €26.46 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.06%.

Volume

Today's last reported volume for GLANBIA PLC is 630838 which is 35.35% above its average volume of 466072.

More news about GLANBIA PLC.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com